Elanco Animal Health Incorporated
ELAN
$10.41
-$0.40-3.70%
| Weiss Ratings | ELAN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | D+ | |||
| Rating Factors | ELAN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Fair | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | ELAN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.78 | |||
| Price History | ELAN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -1.61% | |||
| 30-Day Total Return | -7.47% | |||
| 60-Day Total Return | -14.04% | |||
| 90-Day Total Return | -25.54% | |||
| Year to Date Total Return | -13.61% | |||
| 1-Year Total Return | -34.82% | |||
| 2-Year Total Return | 14.14% | |||
| 3-Year Total Return | -62.19% | |||
| 5-Year Total Return | -53.92% | |||
| 52-Week High % Change | -44.63% | |||
| 52-Week Low % Change | 3.79% | |||
| Price | ELAN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $18.80 | |||
| 52-Week Low Price | $10.03 | |||
| 52-Week Low Price (Date) | Mar 11, 2025 | |||
| 52-Week High Price (Date) | Jun 12, 2024 | |||
| Valuation | ELAN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 5.15B | |||
| Enterprise Value | 9.12B | |||
| Price/Earnings (TTM) | 15.56 | |||
| Earnings Per Share (TTM) | 0.67 | |||
| Earnings Per Share Growth | -126.71% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.16 | |||
| Price/Book (Q) | 0.84 | |||
| Enterprise Value/Revenue (TTM) | 2.06 | |||
| Price | $10.41 | |||
| Enterprise Value/EBITDA (TTM) | 10.38 | |||
| Enterprise Value/EBIT | 35.51 | |||
| Market Cap Category | Mid Cap | |||
| Dividends and Shares | ELAN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 494.40M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ELAN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 877 352 6261 | |||
| Address | 2500 Innovation Way Greenfield, IN 46140 | |||
| Website | www.elanco.com | |||
| Country | United States | |||
| Year Founded | 1954 | |||
| Profitability | ELAN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 5.78% | |||
| Profit Margin | 7.61% | |||
| Management Effectiveness | ELAN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 1.19% | |||
| Return on Equity | 5.49% | |||
| Income Statement | ELAN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 4.44B | |||
| Total Revenue (TTM) | 4.44B | |||
| Revenue Per Share | $8.98 | |||
| Gross Profit (TTM) | 2.44B | |||
| EBITDA (TTM) | 879.00M | |||
| EBIT (TTM) | 257.00M | |||
| Net Income (TTM) | 338.00M | |||
| Net Income Avl. to Common (TTM) | 338.00M | |||
| Total Revenue Growth (Q YOY) | -1.45% | |||
| Earnings Growth (Q YOY) | 94.33% | |||
| EPS Diluted (TTM) | 0.67 | |||
| EPS Diluted Growth (Q YOY) | 93.26% | |||
| Balance Sheet | ELAN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 468.00M | |||
| Cash Per Share (Q) | $0.95 | |||
| Total Current Assets (Q) | 3.22B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 6.10B | |||
| Current Ratio (Q) | 2.445 | |||
| Book Value Per Share (Q) | $12.33 | |||
| Total Assets (Q) | 12.61B | |||
| Total Current Liabilities (Q) | 1.32B | |||
| Total Debt (Q) | 4.44B | |||
| Total Liabilities (Q) | 6.52B | |||
| Total Common Equity (Q) | 6.10B | |||
| Cash Flow | ELAN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 1.16B | |||
| Cash from Financing (TTM) | -1.49B | |||
| Net Change in Cash (TTM) | 116.00M | |||
| Levered Free Cash Flow (TTM) | 917.75M | |||
| Cash from Operations (TTM) | 541.00M | |||
